Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Europe Cancer Diagnostics Market Sees Promising Growth Amid Rising Demand for Precision Diagnostics - Forecasts to 2031 | ||
By: PR Newswire Association LLC. - 02 Mar 2024 | Back to overview list |
|
DUBLIN, March 1, 2024 /PRNewswire/ -- The "Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]), Cancer Type (Breast, Lung, Colon, Prostate), and End User (Hospital, Imaging Center, Pharmaceutical) - Forecast to 2031" report has been added to ResearchAndMarkets.com's offering. The comprehensive market study indicates a compounded annual growth rate of 5.6% leading up to 2031, highlighting the escalating urgency to tackle the diverse types of cancer more effectively. A surge in cancer research funding, combined with a solid backing of initiatives aimed at promoting early detection, are key factors enhancing the market's potential. Specialists are particularly bullish about the strides in precision diagnostics, presenting ground-breaking opportunities within the sector. The latest report on the Europe cancer diagnostics market projects a robust growth trajectory for the industry, setting high expectations for advancements in cancer care across the continent. Detailed analysis points to significant market expansion, driven by the increasing incidence of cancer and a potent rise in the region's readiness to adopt cutting-edge diagnostic technologies. Key Market Dynamics Shaping Europe's Cancer Diagnostics Despite the optimism, the market faces challenges such as the high costs associated with imaging systems and a pronounced skills gap that hinders optimum implementation of comprehensive screening programs. Products and Innovations: Spotlight on the IVD Segment Breast Cancer Diagnosis Leads the Cancer Type Segments Breast cancer diagnostics stands as a notable segment bolstered by growing healthcare investment and reimbursement adjustments for cutting-edge technologies like Next-Generation Sequencing (NGS). Notably, an increase in awareness programs led by renowned medical establishments is significantly influencing the diagnostics landscape. End Users: Hospitals & Diagnostic Laboratories at the Forefront Hospitals and diagnostic laboratories are envisaged to maintain a stronghold in the end-user segment. Their significant market share is a testament to their pivotal role in harnessing advanced diagnostics, scaling up cancer care protocols, and the extension of their state-of-the-art infrastructural facilities. Regional Insights: Germany Leads Amidst High Growth in European Countries Forecasts Through 2031: The market size, segment analysis, and country-wise breakdowns encapsulated in the report provide investors, healthcare providers, and policymakers with a comprehensive understanding of the current trends and future projections in cancer diagnostics. The document acts as a crucial guide in strategic planning and resource allocation across Germany, France, the UK, Italy, Spain, Switzerland, the Netherlands, and the rest of the European region. Notable stakeholders in the market, such as industry-leading healthcare companies and tech innovators, continue to push the envelope in diagnostic precision, striving to make early and accurate cancer detection more accessible to patients across Europe. The insights gained through this report empower stakeholders to navigate the market with greater clarity, optimize their operational models, and ultimately, contribute to the betterment of cancer diagnostics outcomes for patients throughout Europe.
Key questions answered in the report:
Market Insights Factors Affecting Market Growth
Trends Regulatory Analysis
Porter's Five Forces Analysis: Diagnostic Imaging Technologies for Cancer Screening Porter's Five Forces Analysis: IVD Technologies for Cancer Screening Pricing Analysis Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments, SWOT Analysis)
Competition Analysis
Scope of the Report:
(Other imaging consumables include films, gels, transducers, and probes, among others)
Europe Cancer Diagnostics Market Size & Trend Analysis - by Cancer Type
Note: Other cancer types include leukemia, lymphoma, stomach, ovarian, melanoma, kidney, and cervical cancers.
Europe Cancer Diagnostics Market Size & Trend Analysis - by Country
For more information about this report visit https://www.researchandmarkets.com/r/9uj181 About ResearchAndMarkets.com
Research and Markets Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg View original content:https://www.prnewswire.com/news-releases/europe-cancer-diagnostics-market-sees-promising-growth-amid-rising-demand-for-precision-diagnostics---forecasts-to-2031-302077399.html SOURCE Research and Markets |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |